{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-012813","form_type":"8-K","ticker":null,"cik":"0001591165","company_name":"Innoveren Scientific, Inc.","filed_at":"2023-04-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.563147+00:00","generated_at":"2026-06-17T00:44:17.137152+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"H-CYTE raises $135,000 in convertible note offering with warrants","bullets":["Sold $135,000 of 8% convertible promissory notes to three investors under SPA.","Notes convertible at 20% discount to qualified offering price; $100k matures 1 year or qualified closing, $35k matures 60 days.","Warrants for 20% of conversion shares at $2.00 exercise price, 5-year term.","Part of up to $1M offering; further closings through April 30, 2023 (extendable to June 30).","Issued under Section 4(a)(2) and Rule 506(b) exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-012813","json":"https://secwatch.observer/filing/0001493152-23-012813.json","markdown":"https://secwatch.observer/filing/0001493152-23-012813.md","text":"https://secwatch.observer/filing/0001493152-23-012813.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1591165/000149315223012813/0001493152-23-012813-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1591165/000149315223012813/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T00:44:17.137152+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c14dbfe7a76b15fa39b7d094dbd70fcd9d4ab33a","claim":"Innoveren Scientific, Inc. incurred convertible notes of $135,000 with three investors at 8% per annum maturing earlier of (i) one year from issuance; or (ii) upon the closing of a qualified offering.","evidence_excerpt":"On April 12, 2023, H-Cyte, Inc., (the “Company”) and three investors entered into a Securities Purchase Agreement (the “SPA”), whereby, the Company sold and issued to the certain investors, an aggregate of one hundred thirty five thousand dollars ($135,000.00) of the Company’s convertible promissory notes","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1591165/000149315223012813/0001493152-23-012813-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$135,000"},{"label":"Counterparty","value":"three investors"},{"label":"Rate","value":"8% per annum"},{"label":"Maturity","value":"earlier of (i) one year from issuance; or (ii) upon the closing of a qualified offering"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"},{"claim_id":"f816371d8f73ede39ffaac079d5c696dc1962e83","claim":"Innoveren Scientific, Inc. entered into Securities Purchase Agreement with three investors valued at $135,000.00 (effective 2023-04-12).","evidence_excerpt":"On April 12, 2023, H-Cyte, Inc., (the “Company”) and three investors entered into a Securities Purchase Agreement (the “SPA”), whereby, the Company sold and issued to the certain investors, an aggregate of one hundred thirty five thousand dollars ($135,000.00) of the Company’s convertible promissory notes","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1591165/000149315223012813/0001493152-23-012813-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"three investors"},{"label":"Value","value":"$135,000.00"},{"label":"Effective","value":"2023-04-12"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}